ICD-10 Coding for Thrombocytopenic Disorder(D69.0, D69.3, D69.3B)
Comprehensive guide to ICD-10 coding for thrombocytopenic disorders, including immune thrombocytopenic purpura and heparin-induced thrombocytopenia.
Complete code families applicable to Thrombocytopenic Disorder
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| D69.3 | Immune thrombocytopenic purpura (ITP) | Use when ITP is confirmed by laboratory tests and clinical evaluation. |
|
| D75.82 | Heparin-induced thrombocytopenia (HIT) | Use when thrombocytopenia is linked to heparin use and confirmed by lab tests. |
|
| D69.6 | Unspecified thrombocytopenia | Use only when specific causes are not identified. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutThrombocytopenic Disorder
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Thrombocytopenic Disorder.
Failure to document etiology of thrombocytopenia.
Impact
Clinical: Leads to inappropriate treatment., Regulatory: Increases audit risk., Financial: May result in denied claims.
Mitigation
Use templates to ensure all elements are documented., Educate providers on documentation requirements.
Using D69.6 when a more specific code is available.
Impact
Reimbursement: May result in lower reimbursement rates., Compliance: Increases risk of audit and non-compliance., Data Quality: Reduces accuracy of patient records.
Mitigation
Ensure documentation specifies the type of thrombocytopenia.
Unspecified Thrombocytopenia Coding
Impact
High audit risk when using D69.6 without specific documentation.
Mitigation
Document specific causes and lab results.